期刊文献+

85例儿童孤独症临床分析 被引量:8

Clinical analysis on 85 autistic children
在线阅读 下载PDF
导出
摘要 目的 探讨儿童孤独症的临床特征以及相应的干预措施。方法 调查患儿首诊主诉、发病与就诊时间间隔、个人史以及家庭史。采用PPVT、DDST智力量表,CARS、ABC孤独症量表以及ADQ儿童适应行为评定量表进行测试。结果 85例患儿临床症状完全符合DSM-Ⅳ儿童孤独症诊断标准。临床特征以社会交往障碍、言语障碍、智力迟滞以及主动回避与他人眼对视为主。患儿从发病到就诊时间平均延迟22个月。45例(占53%)患儿系由剖宫产或产钳助产而娩出。结论 作者提出早期发现,早期干预以及综合性行为、语言等训练对孤独症来说至关重要。 Objectives: To explore clinical feature and appropriate intervention for autistic children. Method: To investigate interval between first onset and first consultation, personal and family history in autistic children. All subjects were tested with PPVT. DDST. Childhood Autism Behavior Rating Scale (CARS), ABC and Adaptive Behavior Check List (ADQ). Results: 85 autistic children met DSM- IV diagnostic criterion were included. Their primary clinical features included communication retardation, speech disorder, mental retardation and poor eyes contact. The average interval between first onset and first consultation was 22 months. Forty-five (53%) cases were delivered throngh cesarean section or obstetric pliers. Conclusion: Early detection and intervention as synthetic behavior and language training are. therefore of utmost importance for autism.
出处 《上海精神医学》 北大核心 2003年第1期23-26,共4页 Shanghai Archives of Psychiatry
关键词 儿童孤独症 语言障碍 社会交往障碍 Autism Children speech disorder Communication retardation
  • 相关文献

参考文献11

二级参考文献14

  • 1杨晓玲 陶国泰.临床评定量表.儿童少年精神医学[M].南京:江苏科学技术出版社,1999.128.
  • 2杨晓玲 李雪荣.广泛性发育障碍.现代儿童精神医学[M].长沙:湖南科学技术出版社,1994.174-191.
  • 3[1]Cook EH Jr, Courchesne R, Lord C, et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry, 1997, 2(3): 247
  • 4[2]Herault J, Petit E, Martineau J, et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Res, 1996, 65(1): 33
  • 5[3]Purdon SE, Lit W, Labelle A, et al. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry, 1994, 39(7): 400
  • 6[4]McDougle CJ, Holmes JP, Carlosn DC, et al. A double-blind, placebocontrolled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry, 1998, 55(7):633
  • 7[5]Nicolson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry, 1998, 37(4):372
  • 8[6]Perry R, Pataki C, Munoz; Silva DM, et al. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and followup. J Child Adolesc Psychopharmacol, 1997, 7(3): 167
  • 9[7]McDougle C J, Holmes JP, Bronson MR, et al. Risperidone treament of children and adolescents with pervasive developmental disorders: a prospective open-label study. Am Acad Child Adolesc Psychiatry, 1997,36(5): 685
  • 10[8]Findling RL, Maxwell K, Wiznitzer M. An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull, 1997, 33(1): 155

共引文献109

同被引文献64

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部